Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria
The DOI matches its Crossref record.
Abstract
Blood glucose measurements are generally accepted components of a modern diabetes self-management. The value of self-monitoring of blood glucose (SMBG) is, however, discussed controversially and only a few studies addressed the efficacy of SMBG under real-life conditions so far. In order to investigate whether the frequency of SMBG is related to long-term metabolic control, data from the DPV-Wiss-database, a standardized,prospective, computer-based documentation of diabetes care and outcome, were analyzed for patients with type 1(n = 19,491) and type 2 (n = 5,009) diabetes from 191 centers in Germany and Austria. Local HbA1c reference ranges were mathematically adjusted to the DCCT reference. For each patient, data from the most recent year of diabetes care were used. On average,patients with type 1 diabetes performed 4.4 blood glucose measurements/day. Corrected for age, gender, diabetes duration,on intensified (>or=4 daily injections or CSII) therapy (HbA1c reduction of 0.32% for one additional SMBG/day) compared to patients on conventional (1-3 daily injections) therapy(HbA1c-reduction of 0.16% for one additional SMBG/day). In 2,021 patients with insulin-treated type 2 diabetes (2.7 measurements/day), more frequent SMBG was associated with better metabolic control (HbA1c-reduction of 0.16% for one additionalSMBG/day, p < 0.0001), while in 2,988 patients on OAD or diet alone (2.0 measurements/day), more frequent blood glucose measurements were associated with higher HbA1c-levels(HbA1c-increase of 0.14% for one additional SMBG/day,p < 0.0001). These data indicate that more frequent SMBG are associated with better metabolic control in both, patients with type 1 and insulin-treated type 2 diabetes. Since no benefit ofSMBG on metabolic control was found in patients with type 2 diabetes on OAD or diet alone, SMBG should primarily be recommended for those patients with suboptimal metabolic control whereas the benefit of SHBG in non-insulin-treated patients with adequate HbA1c-levels remains uncertain.insulin therapy and center difference, the SMBG frequency was associated with better metabolic control (HbA1c-reduction of0.26% for one additional SMBG/day, p < 0.0001). HbA1c-reduction with higher frequency of SMBG was more pronounced in patients Blood glucose measurements are generally accepted components of a modern diabetes self-management. The value of self-monitoring of blood glucose (SMBG) is, however, discussed controversially and only a few studies addressed the efficacy of SMBG under real-life conditions so far. In order to investigate whether the frequency of SMBG is related to long-term metabolic control, data from the DPV-Wiss-database, a standardized,prospective, computer-based documentation of diabetes care and outcome, were analyzed for patients with type 1(n = 19,491) and type 2 (n = 5,009) diabetes from 191 centers in Germany and Austria. Local HbA1c reference ranges were mathematically adjusted to the DCCT reference. For each patient, data from the most recent year of diabetes care were used. On average,patients with type 1 diabetes performed 4.4 blood glucose measurements/day. Corrected for age, gender, diabetes duration,insulin therapy and center difference, the SMBG frequency wasassociated with better metabolic control (HbA1c-reduction of 0.26% for one additional SMBG/day, p < 0.0001). HbA1c-reduction with higher frequency of SMBG was more pronounced in patients on intensified (>or= 4 daily injections or CSII) therapy (HbA1c reduction of 0.32% for one additional SMBG/day) compared to patients on conventional (1-3 daily injections) therapy(HbA1c-reduction of 0.16% for one additional SMBG/day). In 2,021 patients with insulin-treated type 2 diabetes (2.7 measurements/day), more frequent SMBG was associated with better metabolic control (HbA1c-reduction of 0.16% for one additionalSMBG/day, p < 0.0001), while in 2,988 patients on OAD or diet alone (2.0 measurements/day), more frequent blood glucose measurements were associated with higher HbA1c-levels(HbA1c-increase of 0.14% for one additional SMBG/day, p < 0.0001). These data indicate that more frequent SMBG are associated with better metabolic control in both, patients with type 1 and insulin-treated type 2 diabetes. Since no benefit of SMBG on metabolic control was found in patients with type 2 diabetes on OAD or diet alone, SMBG should primarily be recommended for those patients with suboptimal metabolic control whereas the benefit of SHBG in non-insulin-treated patients with adequate HbA1c-levels remains uncertain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Monitoring of blood glucose less frequently than three to four times per day in adults and adolescents has been associated with less effective control of glycemia as measured by HbA 1c (150)(151)(152).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [152]
In the citing paper
“In a study of individuals aged 1 to over 65 years and treated with insulin, HbA 1c showed greater improvement with BGM performed 4 or more times per day than with BGM performed less frequently (152).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [152]
Citations
Cites
Still being checked.
Cited by
Items 101–200 of 237
Pfützner, A., Weissmann, J., Mougiakakou, S., Daskalaki, E., Weis, N., & Ziegler, R. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0278 · Cited by 19
Jin, S., Baek, J. H., Suh, S., Jung, C. H., Lee, W. J., Park, C., Yang, H. K., Cho, J., Lee, B., & Kim, J. H. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12728 · Cited by 19
Deeb, A., Yousef, H., Qahtani, N. A., Artan, I., Suliman, S., Tomy, M., Abdulrahman, L., Suwaidi, H. A., Attia, S., & Nagelkerke, N. J. D. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0351-9 · Cited by 19
Hellmund, R., Weitgasser, R., & Blissett, D. (2018) · European Endocrinology · doi:10.17925/ee.2018.14.2.86 · Cited by 17
Glycemic Control in Iranian Children with Type 1 Diabetes Mellitus: Effect of Gender
Setoodeh, A., Mostafavi, F., & Hedayat, T. (2011) · The Indian Journal of Pediatrics · doi:10.1007/s12098-011-0613-8 · Cited by 18
Landgraf, R., Kellerer, M., Aberle, J., Fach, E.-M., Gallwitz, B., Hamann, A., Joost, H., Klein, H., Müller‐Wieland, D., Nauck, M. A., et al. (2018) · Diabetologie und Stoffwechsel · doi:10.1055/a-0598-0475 · Cited by 18
Glycemic Status Assessment by the Latest Glucose Monitoring Technologies
Malandrucco, I., Russo, B., Picconi, F., Menduni, M., & Frontoni, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218243 · Cited by 17
Ziegler, R., Eichholz, R., & Schulz, B. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815587936 · Cited by 16
Johari, S. M., Razalli, N. H., Chua, K. J., & Shahar, S. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01379-9 · Cited by 17
Chae, M., Reith, D. M., Tomlinson, P. A., Rayns, J. A., & Wheeler, B. J. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-13-14 · Cited by 16
B. Davidson, M. (2010) · Reviews on Recent Clinical Trials · doi:10.2174/157488710792007248 · Cited by 15
“Reprinted with permission from reference [2].”
Chang, Y.-T., Tu, Y.-Z., Chiou, H., Lai, K., & Yu, N. C. (2022) · JMIR mhealth and uhealth · doi:10.2196/31764 · Cited by 15
Davey, B., & Segal, D. G. (2015) · South African Medical Journal · doi:10.7196/samj.7686 · Cited by 15
Chien, M.-N., Chen, Y., Hung, Y., Wang, S., Lu, W.-T., Chen, C., Lin, C., Huang, T., Tsai, M., Tseng, W., et al. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12532 · Cited by 15
The Utility and Recent Advances in Self-Monitoring of Blood Glucose in Type 1 Diabetes
Subramanian, S. L., & Hirsch, I. B. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0010 · Cited by 15
Alshannaq, H. A., Pollock, R. F., Joubert, M., Ahmed, W., Norman, G. J., Lynch, P. M., & Roze, S. (2024) · Journal of Comparative Effectiveness Research · doi:10.57264/cer-2023-0174 · Cited by 14
Assessment of metabolic control among patients in a capillary glucose self-monitoring program
Veras, V. S., de Araújo, M. F. M., Rodrigues, F. F. L., dos Santos, M. A., Damasceno, M. M. C., & Zanetti, M. L. (2012) · Acta Paulista de Enfermagem · doi:10.1590/s0103-21002012000300021 · Cited by 14
Johansen, M. D., Gjerløv, I., Christiansen, J. S., & Hejlesen, O. K. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600221 · Cited by 14
Mobile health (m-Health) for diabetes management
Istepanian, R. S. H., Casiglia, D., & Gregory, J. W. (2017) · British Journal of Healthcare Management · doi:10.12968/bjhc.2017.23.3.102 · Cited by 14
Optimal therapy recommendations for the prescribing and use of blood glucose test strips.
(2010) · Europe PMC (PubMed Central) · Cited by 14
Sildorf, S. M., Hertel, N. T., Thomsen, J., Fredheim, S., Hastrup, H., Pipper, C. B., Hertz, B., & Svensson, J. (2015) · Diabetic Medicine · doi:10.1111/dme.12900 · Cited by 13
Baltacı, D., Kutlucan, A., Öztürk, S., Sarıtaş, A., Çeler, A., Celbek, G., Deler, M. H., Aydın, Y., & Ankaralı, H. Ç. (2012) · PubMed · Cited by 13
Muller, N., Stengel, Kloos, Ristow, M., Wolf, & Müller, U. A. (2012) · International Journal of General Medicine · doi:10.2147/ijgm.s28505 · Cited by 13
Blutzuckerselbstkontrolle Update 2023
Wascher, T. C., Stechemesser, L., Harreiter, J., & Leitlinien, A. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02172-w · Cited by 12
Overland, J., Abousleiman, J., Chronopoulos, A., Leader, N. J., Molyneaux, L. M., & Gilfillan, C. P. (2014) · Diabetes Therapy · doi:10.1007/s13300-014-0092-9 · Cited by 12
Cooper, J. G., Bakke, Å., Dalen, I., Carlsen, S., Skeie, S., Løvaas, K. F., Sandberg, S., & Thue, G. (2019) · Diabetic Medicine · doi:10.1111/dme.14123 · Cited by 12
Addressing the burdens of Type 1 diabetes in youth
Bollepalli, S., SMITH, L. B., Vasquez, A. L., Rodriguez, H., & Vehik, K. (2012) · Clinical Practice · doi:10.2217/cpr.12.33 · Cited by 12
Nadkarni, A., Kucukarslan, S. N., Bagozzi, R. P., Yates, J. F., & Erickson, S. R. (2010) · Patient Education and Counseling · doi:10.1016/j.pec.2010.09.027 · Cited by 12
Matsuoka, A., Hirota, Y., Urai, S., Hamaguchi, T., Takeuchi, T., Miura, H., Otowa‐Suematsu, N., So, A., Nakamura, T., Komada, H., et al. (2018) · Diabetology International · doi:10.1007/s13340-018-0344-4 · Cited by 12
Pereira, M. G., Pedras, S., Ferreira, G., & Machado, J. C. (2018) · Journal of Health Psychology · doi:10.1177/1359105318780505 · Cited by 12
Sieber, J., Flacke, F., Link, M., Haug, C., & Freckmann, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0306-z · Cited by 11
“The frequency of SMBG measurements has been shown to be associated with improvement in HbA1c in patients with T1DM [9], as well as in insulin-treated patients with T2DM [10].”
BackgroundSignificance of the CGM metric of time in range in children and adolescents with type 1 diabetes
Urakami, T. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej22-0257 · Cited by 11
Awareness regarding complications of type II diabetes mellitus among diabetics in Karachi, Pakistan
Younis, H., Younis, S., & Ahmed, S. (2019) · INTERNATIONAL JOURNAL OF ENDORSING HEALTH SCIENCE RESEARCH (IJEHSR) · doi:10.29052/ijehsr.v7.i1.2019.47-54 · Cited by 11
Stachow, R., Schiel, R., Koch, S., Fiedler, S., Hermann, T., & Holl, R. W. (2013) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-013-2909-4 · Cited by 10
Self-citationSjoeholm, A., Gray, A. R., Rayns, J. A., Tomlinson, P. A., & Wheeler, B. J. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0855-z · Cited by 10
Trends in Blood Glucose Test Strip Utilization: A Population-Wide Analysis in Saskatchewan, Canada
Kosar, L., Alsabbagh, M. W., Lu, X., Lix, L. M., Shevchuk, Y. M., Teare, G. F., Champagne, A., & Blackburn, D. F. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.01.004 · Cited by 10
Flash glucose monitoring and glycemic control in type 1 diabetes with subcutaneous insulin infusion
Pinheiro, S. L., Bastos, M., Barros, L. M., Melo, M., & Paiva, I. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01827-2 · Cited by 9
Eldor, R., Roitman, E., Merzon, E., Toledano, Y., Alves, C., & Tsur, A. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.02.004 · Cited by 10
Self-Monitoring of Blood Glucose in Insulin-Requiring Type 2 Diabetes
Naik, R. G., & Ellis, S. L. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0030 · Cited by 9
Thapar, R., Reddy, M. M. R. K., Kumar, N., Hegde, K., Unnikrishnan, B., Mithra, P., Holla, R., Suma, B., Rao, A. M., Nikitha, P., et al. (2023) · F1000Research · doi:10.12688/f1000research.138146.1 · Cited by 8
Chen, M., Liu, M., Pu, Y. D., Wu, J., Zhang, M., Tang, H., Kong, L., Guo, M., Zhu, K., Xie, Y., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1295531 · Cited by 8
Merino-Torres, J. F., Ilham, S., Alshannaq, H. A., Pollock, R. F., Ahmed, W., & Norman, G. J. (2024) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s483459 · Cited by 8
Torres, L. C., & Romero, C. (2022) · Journal of Clinical Nursing · doi:10.1111/jocn.16523 · Cited by 8
Wascher, T. C., & Stechemesser, L. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-015-0927-z · Cited by 9
Self-Monitoring of Blood Glucose—An Overview
Garg, S. K., & Hirsch, I. B. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.1501 · Cited by 8
Wavesense technology glucometer Linus for routine self-monitoring and clinical practice
Chlup, R., Doubravová, B., Peterson, K., Zapletalová, J., & Bartek, J. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0213-5 · Cited by 8
Model-Based Therapeutics for Type 1 Diabetes Mellitus
Wong, X. (2008) · UC Research Repository (University of Canterbury) · doi:10.26021/1222 · Cited by 8
Takita, M., Matsumoto, S., Noguchi, H., Shimoda, M., Chujo, D., Itoh, T., Sugimoto, K., SoRelle, J. A., Onaca, N. N., Naziruddin, B., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1938 · Cited by 7
Jabbour, S. A. (2010) · The Medicine Forum · Cited by 7
Warncke, K., Kummer, S., Kann, P. H., Bergis, D., Bollow, E., Hummel, M., Zoicas, F., Wernert, S., & Holl, R. W. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0600-9649 · Cited by 6
Self-citationGlucometers for Patients with Type 2 Diabetes Mellitus: Are they helpful?
Thomas, A., Shenoy, M. T., Shenoy, K. T., & George, N. (2021) · International Journal of Medical Students · doi:10.5195/ijms.2021.786 · Cited by 6
Setford, S. J., Smith, A. F., McColl, D., Grady, M., Koria, K., & Cameron, H. (2015) · Expert Review of Medical Devices · doi:10.1586/17434440.2015.1102049 · Cited by 6
TYPE 2 DIABETES;: Effects of socio-demographic factors among patients.
Shaikh, Z. A., Akhund, S., Ali, M., & Khan, M. H. (2013) · The Professional Medical Journal · doi:10.29309/tpmj/2013.20.02.628 · Cited by 6
Financial incentives in the management of diabetes: a systematic review
Zhang, Q., Wei, X., Zheng, J., Lu, Y., & Wu, Y. (2024) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-024-00579-4 · Cited by 5
Wehler, E., Lautsch, D., KOWAL, S. L., Davies, G., Briggs, A. H., Li, Q., Rajpathak, S. N., & Alsumali, A. (2020) · PharmacoEconomics · doi:10.1007/s40273-020-00967-7 · Cited by 5
Assessment of metabolic control among patients in a capillary glucose self-monitoring program
Veras, V. S., de Araújo, M. F. M., Rodrigues, F. F. L., dos Santos, M. A., Damasceno, M. M. C., & Zanetti, M. L. (2012) · Acta Paulista de Enfermagem · doi:10.1590/s0103-21002012005000012 · Cited by 5
Tătaru, I., Dragostin, O. M., Fulga, I., Boros, F., Carp, A., Maftei, A., Zamfir, C. L., & Nechita, A. (2022) · Expert Review of Medical Devices · doi:10.1080/17434440.2022.2113387 · Cited by 5
Kesavadev, J., Chandran, G. B., Basanth, A., Krishnan, G., Shankar, A., & Jothydev, S. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102731 · Cited by 5
VALIDATION OF THE QUESTIONNAIRE OF PLANNED BEHAVIOR ON DIABETES: PHYSICAL ACTIVITY
Ferreira, G., & Pereira, M. G. (2014) · Psicologia Saúde & Doenças · doi:10.15309/14psd150207 · Cited by 5
Thoughts on paediatric diabetes care in the UK
Krone, N. P., Högler, W., & Barrett, T. G. (2009) · The British Journal of Diabetes · doi:10.1177/1474651409350950 · Cited by 5
Hortensius, J., Kleefstra, N., Landman, G. W. D., Houweling, B. T., Groenier, K. H., van der Bijl, J. J., & Bilo, H. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3138-7 · Cited by 4
Tienstra, M., Been, R. A., de Boer, J. W., Gans, R. O. B., van Beek, A. P., Kooistra, H., Wiersma, V. R., Mustafa, O. G., Choudhary, P., van Meerten, T., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0232 · Cited by 4
Alzaid, A., Schlaeger, C., & Hinzmann, R. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0260 · Cited by 4
Metabolic Correction in Patients Sample with Diabetes: Clinical Outcomes and Costs Reductions.
Miranda-Massari, J. R., Rodríguez-Gómez, J., González, M. J., Cidre, C., Duconge-Soler, J., Marín-Centeno, H., Grace, K., & McLeod, H. L. (2016) · PubMed · Cited by 4
(2010) · Europe PMC (PubMed Central) · Cited by 4
Knowles, S. R., Lee, K., Paterson, J. M., Shah, B. R., Mamdani, M., Juurlink, D. N., & Gomes, T. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.08.225 · Cited by 4
Point-of-Care Diabetes Management Softwares and Smart Applications
Vashist, S. K. (2019) · Springer eBooks · doi:10.1007/978-3-030-11416-9_4 · Cited by 4
Can the current healthcare delivery model cope with advanced type 2 diabetes?
Hodish, I. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.01.005 · Cited by 4
Self-Monitoring of Blood Glucose: One STeP Forward?
Schramm, W. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600432 · Cited by 4
Zuijdwijk, C., Pendsey, S., Ron, J., Williams, K., Akiki, S., Chalkhore, S., Ogle, G. D., & Ahmet, A. H. (2017) · Journal of Diabetology · doi:10.4103/jod.jod_3_17 · Cited by 3
Maran, A., Tschoepe, D., Mauro, M. D., Fisher, W. A., Loeffler, K., Vesper, I., Bloethner, S., Mast, O., Weissmann, J., Amann-Zalán, I., et al. (2014) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2014.08.003 · Cited by 3
Nayak, B. S., Gowrie, K., Romano, R., Spencer, C., Noel, D., Bissoon, H., Dipatene, I., Mahabir, N., Ragbir, R., & Xavier, S. (2012) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2012.23046 · Cited by 3
Therapy of Type 1 Diabetes Mellitus
Cohan, P., & Peters, A. L. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_43 · Cited by 3
Self-management practices of type 1 diabetes mellitus
Donepudi, A., & Ayyagari, M. (2018) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0692-4 · Cited by 3
(2006) · CRC Press eBooks · doi:10.1201/9781420003864-76 · Cited by 3
Schweiger, D. Š., & Battelino, T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816714-4.00001-6 · Cited by 3
Psychological determinants and self care in patients with type 1 diabetes
Ahola, A. J. (2012) · Helda - University of Helsinki Institutional Repository · Cited by 3
Pavese, F. (2025) · Medical Research Archives · doi:10.18103/mra.v13i8.6697 · Cited by 2
Agha, A. E. A. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000548 · Cited by 2
Evidence of patient self-testing at clinic review: association with glycaemic control
Whyte, M., Manu, C. A., Hopkins, D., & Thomas, S. (2015) · The British Journal of Diabetes · doi:10.15277/bjdvd.2015.015 · Cited by 2
La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale
Bruttomesso, D., Laviola, L., Lepore, G., Bonfanti, R., Bozzetto, L., AM, C., Blasi, V. D., Girelli, A., Grassi, G., Iafusco, D., et al. (2015) · ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) · Cited by 2
Petrov, A. V., Александровна, К. А., Suvorova, L. A., Strongin, L. G., Владимировна, Л. Д., & Петрович, Г. С. (2012) · Diabetes Mellitus · doi:10.14341/2072-0351-5516 · Cited by 2
Blutzuckerselbstkontrolle (Update 2019)
Leitlinien, D. A., Wascher, T. C., Stechemesser, L., & Harreiter, J. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-018-1436-7 · Cited by 2
Clinical studies of glucose variability and hypoglycemia in adult patients with type 1 diabetes
Bragd, J. (2011) · Figshare · Cited by 2
Thapar, R., Reddy, M. M. R. K., Kumar, N., Hegde, K., Unnikrishnan, B., Mithra, P., Holla, R., Suma, B., Rao, A. M., Nikitha, P., et al. (2025) · F1000Research · doi:10.12688/f1000research.138146.3 · Cited by 1
Digital technologies in self-monitoring of blood glucose and their clinical significance
Григорьева, И. Н., & Тов, Н. Л. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-168 · Cited by 1
Kim, S., Kang, M., Park, D., Kim, G., & Kim, J. H. (2025) · BMC Public Health · doi:10.1186/s12889-025-24617-9 · Cited by 1
Kobos, E., Kostrzewa-Zabłocka, E., Ławnik, A. J., & Hornik, B. (2026) · Scientific Reports · doi:10.1038/s41598-026-42065-2 · Cited by 1
Diabetes: Diagnose, Epidemiologie, Screening
Rathmann, W. (2007) · Der Diabetologe · doi:10.1007/s11428-007-0162-y · Cited by 1
m ‐Health Care Models and Applications
Istepanian, R. S. H., & Woodward, B. (2016) · Wiley eBooks · doi:10.1002/9781119302889.ch5 · Cited by 1
Chapter 6 Diabetes management software and smart applications
Vashist, S. K., & Luong, J. H. T. (2016) · CRC Press eBooks · doi:10.1201/9781315366746-7 · Cited by 1
Wascher, T. C. (2012) · Wiener klinische Wochenschrift · doi:10.1007/s00508-012-0288-9 · Cited by 1
Fendler, W. M., Hogendorf, A., Szadkowska, A., & Mlynarski, W. M. (2011) · PubMed · Cited by 1
Chapitre 16 – Le diabète de type 2
Wémeau, J.-L. (2014) · doi:10.1016/b978-2-294-71584-6.00016-7 · Cited by 1
Chapitre 15 – Le diabète de type 1
Wémeau, J.-L. (2014) · doi:10.1016/b978-2-294-71584-6.00015-5 · Cited by 1
Betônico, C. D. C. R. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2017.tde-05042017-153224 · Cited by 1
Robust and fault-tolerant strategies for controlling blood glucose in patients with type 1 diabetes
Tantiña, A. B. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Diabetic Nephropathy: a Changing Scenery
Veldman, B. A. J. (2009) · Radboud Repository (Radboud University)
Umsatzveränderungen in einzelnen Indikationsgruppen
Höer, A., & Klein, S. (2012) · Springer eBooks · doi:10.1007/978-3-642-32587-8_3
Metadata
- Authors
- Schütt, M., Kern, Krause, U., Busch, Dapp, A., Grziwotz, Mayer, I., Rosenbauer, Wagner, C., Zimmermann, Kerner, W., & Holl, R.
- Affiliations
- University of Lübeck (DE)
- Universität Ulm (DE)
- SLK-Kliniken Heilbronn (DE)
- Kreiskrankenhaus Gummersbach (DE)
- Deutsches Diabetes-Zentrum e.V. (DE)
- Institute for Diabetes Gerhardt Katsch (DE)
- Venue
- Experimental and Clinical Endocrinology & Diabetes
- Publisher
- Georg Thieme Verlag KG
- Published
- 2006-08-16
- Volume
- 114
- Issue
- 07
- Pages
- 384-388
- ISSN
- 0947-7349 (ISSN-L)
- 1439-3646
- OpenAlex
- W1981356692
- Semantic Scholar
- 0b8be1a894b7fd40002ab06ebec43b86e55db9f1
- Cited by
- 218
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 8 · 2023: 7 · 2022: 8 · 2021: 3 · 2020: 8 · 2019: 12 · 2018: 20 · 2017: 15 · 2016: 10 · 2015: 19 · 2014: 14 · 2013: 10 · 2012: 13
- FWCI
- 8.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental and Clinical Endocrinology & Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bundesministerium für Gesundheit
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- self-monitoring of blood glucose, HbA1c, glycemic control, type 1 diabetes, type 2 diabetes, intensive insulin therapy, insulin pump therapy, oral antidiabetic drugs, diabetes self-management, real-world data
- MeSH terms
- Austria, Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Germany, Homeostasis, Humans, Patient Compliance, Self Care, Blood Glucose Self-Monitoring, Databases, Factual
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.